A phar­ma R&D chief jumps to a bud­ding new start­up fac­to­ry — and this time he’s found 'some­thing com­plete­ly dif­fer­ent’

Over the course of a tu­mul­tuous year, Paul Bion­di has been qui­et­ly build­ing a new op­er­a­tion in­side Flag­ship Pi­o­neer­ing, one of the most am­bi­tious biotech builders in the VC world. Look­ing to draw to­geth­er new drug pro­grams out of the Flag­ship ar­ma­da, the Bris­tol My­ers BD vet is set­ting up a slate of sin­gle-as­set com­pa­nies built around new ther­a­peu­tics that can be spun out of the port­fo­lio of plat­form com­pa­nies they spe­cial­ize in.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER